Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.170
+0.030 (2.63%)
At close: Mar 9, 2026, 4:00 PM EDT
1.270
+0.100 (8.55%)
After-hours: Mar 9, 2026, 7:49 PM EDT
Artelo Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2 | 2 | 3 | 4 | 8 | 22 | |
| Market Cap Growth | -36.26% | -28.02% | -23.37% | -45.90% | -62.41% | -1.60% | |
| Enterprise Value | 3 | 2 | -1 | -8 | -11 | 12 | |
| Last Close Price | 1.14 | 1.22 | 6.36 | 8.40 | 17.34 | 46.71 | |
| PB Ratio | - | -1.94 | 1.20 | 0.38 | 0.43 | 0.81 | |
| P/TBV Ratio | - | - | 4.18 | 0.46 | 0.48 | 0.87 | |
| Debt / Equity Ratio | -0.53 | -0.53 | 0.04 | 0.00 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.06 | -0.06 | -0.78 | -0.88 | -0.90 | -0.88 | |
| Net Debt / FCF Ratio | -0.01 | -0.01 | 0.27 | 1.27 | 2.18 | 3.00 | |
| Quick Ratio | 0.15 | 0.15 | 1.32 | 8.08 | 17.57 | 23.48 | |
| Current Ratio | 0.17 | 0.17 | 1.44 | 8.51 | 18.36 | 23.96 | |
| Return on Equity (ROE) | -1625.11% | -1625.11% | -134.52% | -59.63% | -43.30% | - | |
| Return on Assets (ROA) | -190.09% | -190.09% | -71.22% | -37.09% | -26.42% | - | |
| Return on Capital Employed (ROCE) | 917.50% | 917.50% | -345.50% | -84.50% | -53.00% | -44.50% | |
| Earnings Yield | -496.83% | -522.93% | -287.20% | -208.06% | -122.17% | -55.14% | |
| FCF Yield | -328.68% | -345.94% | -244.06% | -183.83% | -97.03% | -36.44% | |
| Buyback Yield / Dilution | -91.62% | -91.62% | -8.85% | -4.48% | -27.04% | -79.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.